Size | Price | Stock | Qty |
---|---|---|---|
25mg |
|
||
50mg |
|
||
100mg |
|
||
250mg |
|
||
500mg |
|
||
1g |
|
||
Other Sizes |
|
Purity: ≥98%
Rifabutin (also known as Ansamycin) is a semisynthetic ansamycin and broad-spectrum antibiotic with potent antimycobacterial properties. Rifabutin is being used as prophylaxis against disseminated Mycobacterium avium complex infection in HIV-positive patients.
Targets |
Antibacterial
|
---|---|
ln Vitro |
Rifabutin is primarily prescribed as an antibiotic with bactericidal properties to treat tuberculosis. Its action on bacteria stems from its semi-synthetic derivative, rifamycin S., which blocks RNA polymerase in a DNA-dependent manner. It works well against a variety of bacteria, including Gram-positive and Gram-negative bacteria, Mycobacterium tuberculosis, M. leprae, and M. avium intracellulare. It is particularly effective against highly resistant mycobacteria. Antibiotic and antitumor drug rifabutin. Rifabutin inhibits the bacterial RNA polymerase, increases ubiquitination and protein degradation, and tampers with the HSP-90 molecular chaperone.
|
References |
|
Molecular Formula |
C46H62N4O11
|
---|---|
Molecular Weight |
847.0047
|
Exact Mass |
846.44
|
Elemental Analysis |
C, 65.23; H, 7.38; N, 6.61; O, 20.78
|
CAS # |
72559-06-9
|
Related CAS # |
Rifabutin-d7;2747918-39-2
|
Appearance |
Solid powder
|
SMILES |
O=C1c2c(O)c(C)c3c(C4=O)c2C5=NC6(CCN(CC(C)C)CC6)NC5=C1NC(/C(C)=C/C=C/[C@@H]([C@H](O)[C@H]([C@@H](O)[C@H]([C@@H]([C@H](C)[C@@H](OC)/C=C/O[C@]4(O3)C)OC(C)=O)C)C)C)=O
|
InChi Key |
ATEBXHFBFRCZMA-NYGPAKPVSA-N
|
InChi Code |
InChI=1S/C46H62N4O11/c1-22(2)21-50-18-16-46(17-19-50)48-34-31-32-39(54)28(8)42-33(31)43(56)45(10,61-42)59-20-15-30(58-11)25(5)41(60-29(9)51)27(7)38(53)26(6)37(52)23(3)13-12-14-24(4)44(57)47-36(40(32)55)35(34)49-46/h12-15,20,22-23,25-27,30,37-38,41,49,52-54H,16-19,21H2,1-11H3,(H,47,57)/b13-12+,20-15+,24-14+/t23-,25+,26+,27+,30-,37-,38+,41+,45-/m0/s1
|
Chemical Name |
Rifamycin XIV, 1',4-didehydro-1-deoxy-1,4-dihydro-5'-(2-methylpropyl)-1-oxo-
|
Synonyms |
Ansamycin; Rifabutin; LM-427; LM 427; LM427; Mycobutin; Rifabutina;
|
HS Tariff Code |
2934.99.03.00
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month |
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
DMSO : 50~100 mg/mL (59.03~118.06 mM)
Ethanol : ~100 mg/mL |
---|---|
Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (2.95 mM) (saturation unknown) in 10% DMSO + 40% PEG300 + 5% Tween80 + 45% Saline (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 400 μL PEG300 and mix evenly; then add 50 μL Tween-80 to the above solution and mix evenly; then add 450 μL normal saline to adjust the volume to 1 mL. Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH₂ O to obtain a clear solution. Solubility in Formulation 2: 10% DMSO+40% PEG300+5% Tween-80+45% Saline  (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 1.1806 mL | 5.9032 mL | 11.8064 mL | |
5 mM | 0.2361 mL | 1.1806 mL | 2.3613 mL | |
10 mM | 0.1181 mL | 0.5903 mL | 1.1806 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.